KRYSTLE COX: Open Payments
NPI 1124762992 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 5 payments from 4 companies in 2025. Trend: 2023 $267 · 2024 $137 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $47 |
| Acella Pharmaceuticals, LLC | 2 | $30 |
| MERZ NORTH AMERICA, INC. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $20 |
Products named: DAXXIFY, NP Thyroid 60, Xeomin, DYSPORT.
Industry payments across FL — which companies pay providers there.
